Showing results (291-300 of 503) with videos related to

Sort By:
Pageof 51
Disease Markers|November 25, 2006
Chemokine receptors as biomarkers in multiple sclerosisRobert J Fox, Pia Kivisäkk, Jar-Chi Lee, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 30, 2023
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experimentTommi Tervonen, Robert J Fox, Anne Brooks, et al.
Neurology. Clinical Practice|November 30, 2017
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participantsStacey S Cofield, Amber Salter, Tuula Tyry, et al.
Multiple Sclerosis and Related Disorders|March 8, 2022
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficientJustin M Leach, Gary Cutter, Daniel Golan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 4, 2023
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trialGary Cutter, Richard A Rudick, Carl de Moor, et al.
Psycho-Oncology|January 24, 2015
Capacity of patients with brain metastases to make treatment decisionsKristen L Triebel, Adam Gerstenecker, Karen Meneses, et al.
Multiple Sclerosis and Related Disorders|June 18, 2024
Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosisRobert W Motl, Prudence Plummer, Deborah Backus, et al.
Journal of Autism and Developmental Disorders|January 30, 2017
Assessment of Caregiver Inventory for Rett SyndromeJane B Lane, Amber R Salter, Nancy E Jones, et al.
Therapeutic Advances in Neurological Disorders|May 20, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSERalf Gold, Douglas L Arnold, Amit Bar-Or, et al.
Clinical Trials (London, England)|January 11, 2021
Importance of incorporating quantitative imaging biomarker technical performance characteristics when estimating treatment effectsNancy A Obuchowski, Erick M Remer, Ken Sakaie, et al.
Pageof 51